| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | Director | Chief Executive Officer +4 more
4 companies
Foehr Matthew W is a President And CEO at OABI with holdings across 4 companies. Recent SEC Form 4 filings include 3 buys and 7 sells.
Estimated insider holdings value: $57.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 10, 2018 | LGND Ligand Pharmaceuticals Inc | President And COO | Sale+OE | 8,881 | $167.63 | $1,488,686.51 | -8.1% | |
| Feb 23, 2018 | LGND Ligand Pharmaceuticals Inc | President And COO | Sale+OE | 5,444 | $152.98 | $832,823.66 | -5.4% | |
| Aug 9, 2017 | LGND Ligand Pharmaceuticals Inc | President And COO | Sale+OE | 6,100 | $127.51 | $777,823.81 | -6.0% | |
| May 18, 2017 | AIXC Aixcrypto Holdings, Inc. | Director | Buy | 18,000 | $0.62 | $11,154.60 | +105.9% | |
| May 12, 2017 | LGND Ligand Pharmaceuticals Inc | President And COO | Sale+OE | 5,621 | $112.20 | $630,650.34 | -5.7% | |
| Mar 2, 2017 | LGND Ligand Pharmaceuticals Inc | President And COO | Sale+OE | 6,879 | $103.39 | $711,213.62 | -7.0% | |
| Nov 15, 2016 | VKTX Viking Therapeutics, Inc. | Director | Buy | 13,000 | $1.21 | $15,678.00 | +49.5% | |
| Aug 5, 2016 | LGND Ligand Pharmaceuticals Inc | President And COO | Sale+OE | 12,500 | $122.14 | $1,526,750.00 | -13.7% | |
| Apr 13, 2016 | VKTX Viking Therapeutics, Inc. | Director | Buy | 20,000 | $1.24 | $24,800.00 | +320.0% | |
| Mar 17, 2016 | LGND Ligand Pharmaceuticals Inc | President And COO | Sale+OE | 6,400 | $96.70 | $618,880.00 | -7.7% |